PPARβ activation induces rapid changes of both AMPK subunit expression and ampk activation in mouse skeletal muscle

Molecular Endocrinology

Volumn 25, Issue 9, 2011, Pages 1487-1498

  Lendoye, E ^a   Sibille, B ^b   Rousseau, A S ^a   Murdaca, J ^a   Grimaldi, P A ^a   Lopez, P ^a  

^a Institut National de la Santé et de la Recherche Mé dicale   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Ligands: GW0742; Nuclear receptors: PPAR

Indexed keywords

[4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID; ACETYL COENZYME A CARBOXYLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE GAMMA 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; UNCLASSIFIED DRUG; PRKAG3 PROTEIN, MOUSE; THIAZOLE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOSE TIME EFFECT RELATION; DOWN REGULATION; GENE OVEREXPRESSION; GROUPS BY AGE; HUMAN; MALE; MOUSE; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RUNNING; SKELETAL MUSCLE; STARVATION; TRAINING; ANIMAL; C57BL MOUSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PROTEIN SUBUNIT;

MUS MUSCULUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DOWN-REGULATION; ENZYME ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; PPAR-BETA; PROMOTER REGIONS, GENETIC; PROTEIN SUBUNITS; STARVATION; THIAZOLES; TRANSCRIPTION, GENETIC;

EID: 80052303616     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0504     Document Type: Article

References (53)

1. Grimaldi PA 2007 Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives. Cell Mol Life Sci 64:2459-2464.
2. Grimaldi PA 2007 Regulatory functions of PPARβ in metabolism: implications for the treatment of metabolic syndrome. Biochim Biophys Acta 1771:983-990.
3. Ehrenborg E, Krook A 2009 Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor δ Pharmacol Rev 61:373-393.
4. Holst D, Luquet S, Nogueira V, Kristiansen K, Leverve X, Grimaldi PA 2003 Nutritional regulation and role of peroxisome proliferator- activated receptor δ in fatty acid catabolism in skeletal muscle. Biochim Biophys Acta 1633:43-50
5. Grimaldi PA 2010 Metabolic and nonmetabolic regulatory functions of peroxisome proliferator-activated receptor β Curr Opin Lipidol 21:186-191.
6. Gaudel C, Schwartz C, Giordano C, Abumrad NA, Grimaldi P 2008 Pharmacological activation of PPARβ promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle. Am J Physiol Endocrinol Metab 295:E297-E304.
7. Luquet S, Gaudel C, Holst D, Lopez-Soriano J, Jehl-Pietri C, Fredenrich A, Grimaldi PA 2005 Roles of PPAR δ in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes. Biochim Biophys Acta 1740:313-317
8. Giordano C, Rousseau AS, Wagner N, Gaudel C, Murdaca J, Jehl- Piétri C, Sibille B, Grimaldi PA, Lopez P 2009 Peroxisome proliferator- activated receptor β activation promotes myonuclear accretion in skeletal muscle of adult and aged mice. Pflugers Arch 458: 901-913
9. Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M, Grimaldi PA 2003 Peroxisome proliferator-activated receptor δ controls muscle development and oxidative capability. FASEB J 17:2299-2301
10. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM 2004 Regulation of muscle fiber type and running endurance by PPAR δ. PLoS Biol 2:e294.
11. Leibowitz MD, Fiévet C, Hennuyer N, Peinado-Onsurbe J, Duez H, Bergera J, Cullinan CA, Sparrow CP, Baffic J, Berger GD, Santini C, Marquis RW, Tolman RL, Smith RG, Moller DE, Auwerx J 2000 Activation of PPAR δ alters lipid metabolism in db/db mice. FEBS Lett 473:333-336.
12. Sprecher DL, Massien C, Pearce G, Billin AN, Perlstein I, Willson TM, Hassall DG, Ancellin N, Patterson SD, Lobe DC, Johnson TG 2007 Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist. Arterioscler Thromb Vasc Biol 27:359-365
13. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM 2003 Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell 113:159-170.
14. Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, Mihaylova MM, Nelson MC, Zou Y, Juguilon H, Kang H, Shaw RJ, Evans RM 2008 AMPK and PPAR δ agonists are exercise mimetics. Cell 134:405-415
15. Carling D 2004 The AMP-activated protein kinase cascade: a unifying system for energy control. Trends Biochem Sci 29:18-24.
16. Hardie DG 2004 The AMP-activated protein kinase pathway: new players upstream and downstream. J Cell Sci 117:5479-5487.
17. Witczak CA, Sharoff CG, Goodyear LJ 2008 AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci 65:3737-3755
18. Winder WW, Hardie DG 1999 AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277:E1-E10.
19. Röckl KS, Hirshman MF, Brandauer J, Fujii N, Witters LA, Goodyear LJ 2007 Skeletal muscle adaptation to exercise training: AMPMol activated protein kinase mediates muscle fiber type shift. Diabetes 56:2062-2069.
20. Long YC, Zierath JR 2006 AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116:1776-1783.
21. Barnes BR, Glund S, Long YC, Hjälm G, Andersson L, Zierath JR 2005 5'-AMP-activated protein kinase regulates skeletal muscle glycogen content and ergogenics. FASEB J 19:773-779.
22. McBride A, Hardie DG 2009 AMP-activated protein kinase-a sensor of glycogen as well as AMP and ATP? Acta Physiol (Oxf) 196: 99-113.
23. Hardie DG, Scott JW, Pan DA, Hudson ER 2003 Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546:113-120.
24. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG 1996 Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271:27879-27887.
25. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Mäkelä TP, Alessi DR, Hardie DG 2003 Complexes between the LKB1 tumor suppressor, STRAD α/β and MO25 α/β are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2:28.
26. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG 2005 Calmodulin-dependent protein kinase kinase- β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2:9-19.
27. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280:29060-29066.
28. Sakamoto K, McCarthy A, Smith D, Green KA, Grahame Hardie D, Ashworth A, Alessi DR 2005 Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 24:1810-1820.
29. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D 2003 LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13:2004-2008.
30. Woods A, Vertommen D, Neumann D, Turk R, Bayliss J, Schlattner U, Wallimann T, Carling D, Rider MH 2003 Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis. J Biol Chem 278:28434-28442.
31. Hudson ER, Pan DA, James J, Lucocq JM, Hawley SA, Green KA, Baba O, Terashima T, Hardie DG 2003 A novel domain in AMPactivated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr Biol 13:861-866.
32. Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S, Feil SC, Jennings IG, Campbell DJ, Witters LA, Parker MW, Kemp BE, Stapleton D 2003 AMPK β subunit targets metabolic stress sensing to glycogen. Curr Biol 13:867-871.
33. Adams J, Chen ZP, Van Denderen BJ, Morton CJ, Parker MW, Witters LA, Stapleton D, Kemp BE 2004 Intrasteric control of AMPK via the γ1 subunitAMPallosteric regulatory site. Protein Sci 13:155-165.
34. Bateman A 1997 The structure of a domain common to archaebacteria and the homocystinuria disease protein. Trends Biochem Sci 22:12-13.
35. Hardie DG, Salt IP, Hawley SA, Davies SP 1999 AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 338(Pt 3):717-722.
36. Frøsig C, Jørgensen SB, Hardie DG, Richter EA, Wojtaszewski JF 2004 5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle. Am J Physiol Endocrinol Metab 286:E411-E417.
37. Wojtaszewski JF, Birk JB, Frøsig C, Holten M, Pilegaard H, Dela F 2005 5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes. J Physiol 564:563-573.
38. Mahlapuu M, Johansson C, Lindgren K, Hjälm G, Barnes BR, Krook A, Zierath JR, Andersson L, Marklund S 2004 Expression profiling of the γ-subunit isoforms of AMP-activated protein kinase suggests a major role for γ3 in white skeletal muscle. Am J Physiol Endocrinol Metab 286:E194-E200.
39. Barnes BR, Marklund S, Steiler TL, Walter M, Hjälm G, Amarger V, Mahlapuu M, Leng Y, Johansson C, Galuska D, Lindgren K, Abrink M, Stapleton D, Zierath JR, Andersson L 2004 The 5'- AMP-activated protein kinase γ 3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem 279:38441-38447.
40. Deshmukh AS, Glund S, Tom RZ, Zierath JR 2009 Role of the AMPK γ 3 isoform in hypoxia-stimulated glucose transport in glycolytic skeletal muscle. Am J Physiol Endocrinol Metab 297: E1388-E1394.
41. Garcia-Roves PM, Osler ME, Holmström MH, Zierath JR 2008 Gain-of-function R225Q mutation in AMP-activated protein kinase γ 3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J Biol Chem 283:35724-35734.
42. Birk JB, Wojtaszewski JF 2006 Predominant α2/β2/γ3 AMPK activation during exercise in human skeletal muscle. J Physiol 577: 1021-1032
43. Mortensen B, Poulsen P, Wegner L, Stender-Petersen KL, Ribel- Madsen R, Friedrichsen M, Birk JB, Vaag A, Wojtaszewski JF 2009 Genetic and metabolic effects on skeletal muscle AMPK in young and older twins. Am J Physiol Endocrinol Metab 297:E956-E964.
44. Wagner KD, Wagner N 2010 Peroxisome proliferator-activated receptor β/γ (PPAR β/γ) acts as regulator of metabolism linked to multiple cellular functions. Pharmacol Ther 125:423-435.
45. Michiels JF, Perrin C, Leccia N, Massi D, Grimaldi P, Wagner N 2010 PPAR β activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1. Pflugers Arch 459:689-703.
46. Krämer DK, Al-Khalili L, Guigas B, Leng Y, Garcia-Roves PM, Krook A 2007 Role of AMP kinase and PPARδ in the regulation of lipid and glucose metabolism in human skeletal muscle. J Biol Chem 282:19313-19320.
47. Krämer DK, Al-Khalili L, Perrini S, Skogsberg J, Wretenberg P, Kannisto K, Wallberg-Henriksson H, Ehrenborg E, Zierath JR, Krook A 2005 Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor δ. Diabetes 54:1157-1163.
48. Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D 2000 Characterization of AMP-activated protein kinase γ -subunit isoforms and their role in AMP binding. Biochem J 346(Pt 3):659-669.
49. Barnes BR, Long YC, Steiler TL, Leng Y, Galuska D, Wojtaszewski JF, Andersson L, Zierath JR 2005 Changes in exercise-induced gene expression in 5'-AMP-activated protein kinase γ 3-null and γ 3 R225Q transgenic mice. Diabetes 54:3484-3489.
50. Milan D, Jeon JT, Looft C, Amarger V, Robic A, Thelander M, Rogel-Gaillard C, Paul S, Iannuccelli N, Rask L, Ronne H, Lundström K, Reinsch N, Gellin J, Kalm E, Roy PL, Chardon P, Andersson L 2000 A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 288:1248-1251.
51. Long YC, Barnes BR, Mahlapuu M, Steiler TL, Martinsson S, Leng Y, Wallberg-Henriksson H, Andersson L, Zierath JR 2005 Role of AMP-activated protein kinase in the coordinated expression of genes controlling glucose and lipid metabolism in mouse white skeletal muscle. Diabetologia 48:2354-23640.
52. Miniou P, Tiziano D, Frugier T, Roblot N, Le Meur M, Melki J 1999 Gene targeting restricted to mouse striated muscle lineage. Nucleic Acids Res 27:e27.
53. _/_ mice. Atherosclerosis 181:29-37